707 related articles for article (PubMed ID: 29408436)
1. Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.
Bosman LP; Sammani A; James CA; Cadrin-Tourigny J; Calkins H; van Tintelen JP; Hauer RNW; Asselbergs FW; Te Riele ASJM
Heart Rhythm; 2018 Jul; 15(7):1097-1107. PubMed ID: 29408436
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
[TBL] [Abstract][Full Text] [Related]
3. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.
Calkins H; Corrado D; Marcus F
Circulation; 2017 Nov; 136(21):2068-2082. PubMed ID: 29158215
[TBL] [Abstract][Full Text] [Related]
4. Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.
Mazzanti A; Ng K; Faragli A; Maragna R; Chiodaroli E; Orphanou N; Monteforte N; Memmi M; Gambelli P; Novelli V; Bloise R; Catalano O; Moro G; Tibollo V; Morini M; Bellazzi R; Napolitano C; Bagnardi V; Priori SG
J Am Coll Cardiol; 2016 Dec; 68(23):2540-2550. PubMed ID: 27931611
[TBL] [Abstract][Full Text] [Related]
5. Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Collaboration.
Cadrin-Tourigny J; Bosman LP; Wang W; Tadros R; Bhonsale A; Bourfiss M; Lie ØH; Saguner AM; Svensson A; Andorin A; Tichnell C; Murray B; Zeppenfeld K; van den Berg MP; Asselbergs FW; Wilde AAM; Krahn AD; Talajic M; Rivard L; Chelko S; Zimmerman SL; Kamel IR; Crosson JE; Judge DP; Yap SC; Van der Heijden JF; Tandri H; Jongbloed JDH; van Tintelen JP; Platonov PG; Duru F; Haugaa KH; Khairy P; Hauer RNW; Calkins H; Te Riele ASJM; James CA
Circ Arrhythm Electrophysiol; 2021 Jan; 14(1):e008509. PubMed ID: 33296238
[TBL] [Abstract][Full Text] [Related]
6. Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a pooled analysis.
Agbaedeng TA; Roberts KA; Colley L; Noubiap JJ; Oxborough D
Europace; 2022 Oct; 24(10):1665-1674. PubMed ID: 35298614
[TBL] [Abstract][Full Text] [Related]
7. Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentation.
Bhonsale A; Te Riele ASJM; Sawant AC; Groeneweg JA; James CA; Murray B; Tichnell C; Mast TP; van der Pols MJ; Cramer MJM; Dooijes D; van der Heijden JF; Tandri H; van Tintelen JP; Judge DP; Hauer RNW; Calkins H
Heart Rhythm; 2017 Jun; 14(6):883-891. PubMed ID: 28215569
[TBL] [Abstract][Full Text] [Related]
8. Arrhythmic outcome of arrhythmogenic right ventricular cardiomyopathy patients without implantable defibrillators.
Wang W; Cadrin-Tourigny J; Bhonsale A; Tichnell C; Murray B; Monfredi O; Chrispin J; Crosson J; Tandri H; James CA; Calkins H
J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1396-1402. PubMed ID: 29894017
[TBL] [Abstract][Full Text] [Related]
9. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
[TBL] [Abstract][Full Text] [Related]
10. Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment.
Cappelletto C; Stolfo D; De Luca A; Pinamonti B; Barbati G; Pivetta A; Gobbo M; Brun F; Merlo M; Sinagra G
Europace; 2018 Jun; 20(FI1):f20-f29. PubMed ID: 28633348
[TBL] [Abstract][Full Text] [Related]
11. Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
Orgeron GM; Te Riele A; Tichnell C; Wang W; Murray B; Bhonsale A; Judge DP; Kamel IR; Zimmerman SL; Tandri H; Calkins H; James CA
Circ Arrhythm Electrophysiol; 2018 Feb; 11(2):e005593. PubMed ID: 29453325
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
[TBL] [Abstract][Full Text] [Related]
13. Clinical Presentation and Outcomes by Sex in Arrhythmogenic Right Ventricular Cardiomyopathy: Findings from the North American ARVC Registry.
Choudhary N; Tompkins C; Polonsky B; McNitt S; Calkins H; Mark Estes NA; Krahn AD; Link MS; Marcus FI; Towbin JA; Zareba W
J Cardiovasc Electrophysiol; 2016 May; 27(5):555-62. PubMed ID: 26840461
[TBL] [Abstract][Full Text] [Related]
14. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator.
Maupain C; Badenco N; Pousset F; Waintraub X; Duthoit G; Chastre T; Himbert C; Hébert JL; Frank R; Hidden-Lucet F; Gandjbakhch E
JACC Clin Electrophysiol; 2018 Jun; 4(6):757-768. PubMed ID: 29929669
[TBL] [Abstract][Full Text] [Related]
15. Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy.
Protonotarios A; Anastasakis A; Panagiotakos DB; Antoniades L; Syrris P; Vouliotis A; Stefanadis C; Tsatsopoulou A; McKenna WJ; Protonotarios N
Europace; 2016 Apr; 18(4):610-6. PubMed ID: 25825460
[TBL] [Abstract][Full Text] [Related]
16. Clinical Features, Genetic Findings, and Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy: Data From a Brazilian Cohort.
Olivetti NQS; Sacilotto L; Wulkan F; D'Arezzo Pessente G; Lombardi Peres de Carvalho M; Moleta D; Tessariol Hachul D; Veronese P; Hardy C; Pisani C; Wu TC; Vieira MLC; de França LA; de Souza Freitas M; Rochitte CE; Bueno SC; Bastos Lovisi V; Krieger JE; Scanavacca M; da Costa Pereira A; da Costa Darrieux F
Circ Arrhythm Electrophysiol; 2023 Feb; 16(2):e011391. PubMed ID: 36720007
[TBL] [Abstract][Full Text] [Related]
17. Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study.
Santangeli P; Dello Russo A; Pieroni M; Casella M; Di Biase L; Burkhardt JD; Sanchez J; Lakkireddy D; Carbucicchio C; Zucchetti M; Pelargonio G; Themistoclakis S; Camporeale A; Rossillo A; Beheiry S; Hongo R; Bellocci F; Tondo C; Natale A
Heart Rhythm; 2012 Aug; 9(8):1200-6. PubMed ID: 22465294
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of patients referred to a tertiary-level inherited cardiac condition clinic with suspected arrhythmogenic right ventricular cardiomyopathy (ARVC).
Aljehani A; Kew T; Baig S; Cox H; Sommerfeld LC; Ensam B; Kalla M; Steeds RP; Fabritz L
BMC Cardiovasc Disord; 2023 Jan; 23(1):14. PubMed ID: 36635648
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
Yin K; Ding L; Li Y; Hua W
Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
[TBL] [Abstract][Full Text] [Related]
20. Fragmented QRS complex predicts the arrhythmic events in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Canpolat U; Kabakçi G; Aytemir K; Dural M; Sahiner L; Yorgun H; Sunman H; Bariş Kaya E; Tokgözoğlu L; Oto A
J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1260-6. PubMed ID: 23845044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
